Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

HIV-1 gp160 (315-329)

Known as: P18(IIIB), P18III(B), P18IIIB 
 
National Institutes of Health

Related topics

Related topics

2 relations

Broader (2)

HIV Envelope Protein gp160Peptide Fragments

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2001
2001
Analysis of the extracellular processing of HIV-1 gp160-derived peptides using monoclonal antibodies specific to H-2Dd molecule complexed with p18-I10 peptide.
The immunodominant peptide of human immunodeficiency virus 1 gp 160 for murine cytotoxic T cells of H-2d haplotype, has been… Expand
Is this relevant?
2000
2000
Analysis of the mechanism for extracellular processing in the presentation of human immunodeficiency virus-1 envelope protein-derived peptide to epitope-specific cytotoxic T lymphocytes.
An immunodominant epitope of human immunodeficiency virus-1 (HIV-1) gp160 recognized by Dd class I major histocompatibility… Expand
Is this relevant?
1999
1999
Recombinant vaccinia viruses expressing an immunodominant epitope of HIV-1 envelope protein within an influenza hemagglutinin cassette predominantly prime epitope-specific CD8+ CTL
SummaryWe constructed recombinant vaccinia viruses (RVV) expressing a 15-residue peptide (P18IIIB; RIQRGPGRAFVTIGK) of gp160… Expand
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5
Is this relevant?
1998
1998
Pilot study of the immunologic effects of recombinant human growth hormone and recombinant insulin-like growth factor in HIV-infected patients.
OBJECTIVE To study the immunologic effects of recombinant human growth hormone (rhGH), recombinant human insulin-like growth… Expand
Is this relevant?
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy, Terms of Service, and Dataset License
ACCEPT & CONTINUE